Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for AMICUS THERAPEUTICS, INC. · Biopharmaceutical company.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income · posted Apr 18, 2026

Official filing document

 Lobbying activity 2
Health Issues

Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.

Medicare/Medicaid

Legislative and regulatory issues affecting SMID rare disease biotech companies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem